Status:
UNKNOWN
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Ovarian Cancer
Peritoneal Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This is a multi-centre, observational (non-interventional) study, designed to follow patients with advanced ovarian fallopian tube and primary peritoneal cancer, who are receiving Niraparib as mainten...
Detailed Description
This is a multi-centre, observational (non-interventional) study, designed to follow patients with advanced ovarian fallopian tube and primary peritoneal cancer, who are receiving Niraparib as mainten...
Eligibility Criteria
Inclusion
- Female patient 18 years old or over
- Patients who are planned to receive Niraparib for advanced ovarian fallopian tube or primary peritoneal cancer,
- Patients who have previously commenced maintenance Niraparib prior to study opening at site
- Deceased patients who have previously been prescribed Niraparib
- Patients able to give written informed consent, complete questionnaires in English and comply with study procedures (if applicable).
Exclusion
- Patients aged \<18 years old
- Patients unable to give informed consent, complete questionnaires in English or comply with study procedures (if applicable).
Key Trial Info
Start Date :
February 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 3 2024
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04295577
Start Date
February 3 2020
End Date
February 3 2024
Last Update
January 21 2022
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal United Hospitals Bath
Bath, United Kingdom, BA1 3NG
2
Belfast Health & Social Care Trust
Belfast, United Kingdom, BT9 7AB
3
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom, B15 2TH
4
University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom, BS2 8ED